Helping women in Atlanta access HIV prevention
An Interactive Systems Approach to Ending the HIV Epidemic Among Women in Atlanta
['FUNDING_R01'] · EMORY UNIVERSITY · NIH-11129657
This project aims to make HIV prevention medication, called PrEP, more available and easier to use for women in Atlanta by connecting it with trusted family planning services.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | EMORY UNIVERSITY (nih funded) |
| Locations | 1 site (ATLANTA, UNITED STATES) |
| Trial ID | NIH-11129657 on ClinicalTrials.gov |
What this research studies
Many women in the Southern US, especially in Atlanta, face challenges in getting PrEP, a medication that prevents HIV. This is partly because they might not know about it, and partly because it's not always offered where they usually get healthcare. Our project wants to change this by working with family planning clinics, which women already trust for their sexual health needs. We will also involve women in designing better ways to offer PrEP, making sure it fits their lives and helps them use it consistently.
Who could benefit from this research
Good fit: Women in Atlanta who are at risk for HIV and seeking family planning services would be the primary focus of this research.
Not a fit: Patients who are not women, do not reside in the Atlanta area, or are not seeking HIV prevention through family planning services may not directly benefit from this specific project.
Why it matters
Potential benefit: If successful, this work could significantly increase the number of women protected from HIV in Atlanta and serve as a model for other regions.
How similar studies have performed: While integrating PrEP into family planning is a relatively new approach, lessons from successful rollouts of HPV vaccines and contraception suggest that effective awareness and delivery models are crucial.
Where this research is happening
ATLANTA, UNITED STATES
- EMORY UNIVERSITY — ATLANTA, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: SALES, JESSICA A — EMORY UNIVERSITY
- Study coordinator: SALES, JESSICA A
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Acquired Immune Deficiency Syndrome Virus, Acquired Immunodeficiency Syndrome Virus